Managing Director & Founder
Dr. Gitlin is the Managing Director and Founder of BluePath Solutions. He started the company in 2013 after working in industry and academia for over 15 years. Dr. Gitlin spent nearly 10 years at Amgen working in Global and European regional offices, across market access related functions supporting research and commercial activities. Dr. Gitlin has launched multiple products globally; and developed pricing and market access strategies for pharmaceutical products across the lifecycle during a dynamic landscape of policy, payment and pricing reforms.
Dr. Gitlin has served multiple roles within the healthcare industry developing and consulting healthcare stakeholders on topics related to HEOR evidence generation, market access, pricing, reimbursement, and value demonstration. He has worked across multiple therapeutic areas with focus on nephrology, oncology, cardiovascular, diabetes, neurosciences, pain, infectious disease. He has and continues to support small molecule, biopharmaceutical, gene therapies, medical devices, and diagnostics across the lifecycle.
Dr. Gitlin is focused on aligning company stakeholders including pricing, market access, contracting, finance, key account management, and health economics on value, market access and pricing related activities to produce a single and consistent voice for decision-making. He is also focused on account specific evidence to translate strategic decisions into external payer value demonstration tools using informed decision-making services encompassing technology, evidence and education.
Matthew holds a Doctor of Pharmacy from the University of California, San Francisco (UCSF) and Bachelors of Science in Chemistry and Biochemistry from University of California, Santa Barbara. He has authored over 50 clinical and health economic publications, and is a volunteer Assistant Professor for the School of Pharmacy at UCSF.
Brian Duffant is a Vice President at BluePath Solutions, providing his clients with insight to the US health care system and deep expertise in creating profitable market access for life science brands.
Mr. Duffant is knowledgeable in the key market access landscape trends impacting biopharmaceutical brand performance. He has launched multiple brands in the US payer environment in addition to developing and executing market access plans for pre-commercial, mid-stage, and late-lifecycle brands.
Prior to joining BluePath, Brian served as a Senior Principal in the Managed Markets Consulting & Analytics practice of IMS Health. His consulting background includes a role as Vice President, Business Development for The Zitter Group, a boutique managed care consulting firm. His biopharmaceutical industry experience includes director-level market access roles at both UCB, Inc. and Bristol-Myers Squibb.
Mr. Duffant’s areas of focus include, but are not limited to, payer access strategy, value proposition development, pricing strategy, contract strategy/execution, contract modeling, payer segmentation, and reimbursement strategy development. His range of experience includes working with both specialty and non-specialty brands across a broad range of therapeutic categories.
Brian holds a B.S. in Business Administration from San Diego State University and certification as a Professional, Academy of Healthcare Management from the Academy of Healthcare Management.
Vidya Beckman is a Senior Director at BluePath Solutions. She brings 18 years of biopharmaceutical and academic experience spanning medical affairs, population health, payer reimbursement & access, and value communication.
Vidya spent over 10 years at Amgen, where she lead US and global scientific and payer communication activities for numerous products across pre-, peri-, and post-launch phases. Her therapeutic experience includes oncology, cardiovascular disease, bone health, neuroscience, and inflammation. Prior to Amgen, Vidya spent 8 years at the Johns Hopkins Center for Communication Programs managing global research and communication projects focused on population health and infectious disease.
Vidya brings to her clients the ability to translate complex health economic concepts to impactful tools that resonate with customers. She evaluates payer and health care trends to deliver insights that inform evidence-generation, strategic customer engagement, and communication plans and tactics. Vidya also has extensive experience implementing US FDAMA 114 legislation to bolster value communication by manufacturers to payers, complemented by a strong understanding of the regulatory process. Vidya is a relationship builder, skilled in navigating matrixed environments to understand and meet the needs of stakeholders.
Vidya holds an MPH and MBA from Johns Hopkins University, and a Certificate in HEOR from the University of Washington. In her spare time, Vidya is an aspiring sailor, a sci-fi movie addict, and an intrepid foodie.